These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3371093)

  • 1. Pimobendane (UD-CG 115 BS) in chronic congestive heart failure. Short-term and one-month effects of a new inotropic vasodilating agent.
    Renard M; Walter M; Liebens I; Dresse A; Bernard R
    Chest; 1988 Jun; 93(6):1159-64. PubMed ID: 3371093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimobendane (UD-CG 115 BS) in the treatment of severe congestive heart failure. An acute haemodynamic cross-over and double-blind study with two different doses.
    Walter M; Liebens I; Goethals H; Renard M; Dresse A; Bernard R
    Br J Clin Pharmacol; 1988 Mar; 25(3):323-9. PubMed ID: 3282531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects and plasma level profile of pimobendan (UD-CG 115 BS) and its metabolite UD-CG 212 in patients with congestive heart failure after single and repeated oral dosing.
    Hagemeijer F; Brand HJ; Roth W
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):302-10. PubMed ID: 2476606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.
    Mancini D; Keren G; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1988 Oct; 116(4):1008-16. PubMed ID: 3177174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
    Petein M; Levine TB; Cohn JN
    Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RO13-6438, a new inotrope-vasodilator: systemic and coronary hemodynamic effects in congestive heart failure.
    Daly PA; Chatterjee K; Viquerat CE; Parmley WW; Curran D; Scheinbaum M; Anderson S
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1539-44. PubMed ID: 4003296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure.
    Hagemeijer F; Roth W; Brand HJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S57-64. PubMed ID: 2478794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of a new type III phosphodiesterase inhibitor (CI-914) for congestive heart failure.
    Jafri SM; Burlew BS; Goldberg AD; Rogers A; Goldstein S
    Am J Cardiol; 1986 Feb; 57(4):254-9. PubMed ID: 3511661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MDL 17,043 therapy in severe congestive heart failure: characterization of the early and late hemodynamic, pharmacokinetic, hormonal and clinical response.
    Uretsky BF; Generalovich T; Verbalis JG; Valdes AM; Reddy PS
    J Am Coll Cardiol; 1985 Jun; 5(6):1414-21. PubMed ID: 3158689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic effects of pimobendan given orally in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
    Hagemeijer F; Brand HJ; van Mechelen R
    Am J Cardiol; 1989 Mar; 63(9):571-6. PubMed ID: 2919561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemodynamic effects of levosimendan for low cardiac output after cardiac surgery: a case series.
    Malliotakis P; Xenikakis T; Linardakis M; Hassoulas J
    Hellenic J Cardiol; 2007; 48(2):80-8. PubMed ID: 17489345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril in congestive heart failure: acute hemodynamic and neurohumoral evaluation and short-term follow-up.
    Lin M; Chiang HT; Chang MS; Kong CW; Wang SP; Chiang BN
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Jul; 48(1):31-40. PubMed ID: 1679372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and hemodynamic improvement of congestive heart failure by long-term vasodilator therapy with postjunctional alpha 1-adrenoceptor blockade.
    Bertel O; Bühler FR; Burkart F
    J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S181-6. PubMed ID: 6175837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989 May; 13(5):730-8. PubMed ID: 2472521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
    Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
    J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of bromocriptine in patients with congestive heart failure.
    Francis GS; Parks R; Cohn JN
    Am Heart J; 1983 Jul; 106(1 Pt 1):100-6. PubMed ID: 6346844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acute and long-term effects of pimobendan (UD-CG 115) in NYHA II and III heart failure. Results of a randomized multicenter double-blind study].
    Assmann I; Kassel P; Duck HG; Fiehring H; Morgan P; Schmidt PK; Höfs T; Nehmiz G
    Z Kardiol; 1991 Nov; 80(11):687-94. PubMed ID: 1792811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.